Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients

被引：15

作者：

Mo, Yin ^{[1
,2
,3
]}

Hernandez-Koutoucheva, Anastasia ^{[2
]}

Musicha, Patrick ^{[2
,5
]}

Bertrand, Denis ^{[4
]}

Lye, David ^{[3
,6
,7
,8
]}

Ng, Oon Tek ^{[6
,7
]}

Fenlon, Shannon N. ^{[4
]}

Chen, Swaine L. ^{[3
,4
]}

Ling, Moi Lin ^{[9
]}

Tang, Wen Ying ^{[8
]}

Barkham, Timothy ^{[8
]}

Nagarajan, Niranjan ^{[3
,4
]}

Cooper, Ben S. ^{[2
,5
]}

Marimuthu, Kalisvar ^{[3
,7
,8
]}

机构：

[1] Natl Univ Singapore Hosp, Singapore, Singapore

[2] Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand

[3] Natl Univ Singapore, Singapore, Singapore

[4] Genome Inst Singapore, Singapore, Singapore

[5] Univ Oxford, Oxford, England

[6] Nanyang Technol Univ, Singapore, Singapore

[7] Natl Ctr Infect Dis, Singapore, Singapore

[8] Tan Tock Seng Hosp, Singapore, Singapore

[9] Singapore Gen Hosp, Singapore, Singapore

来源：

EMERGING INFECTIOUS DISEASES | 2020年 / 26卷 / 09期

基金：

英国惠康基金; 英国医学研究理事会;

关键词：

RESISTANT ENTEROBACTERIACEAE;

D O I：

10.3201/eid2609.190592

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

To determine the duration of carbapenemase-producing Enterobacteriaceae (CPE) carriage, we studied 21 CPE carriers for approximate to 1 year. Mean carriage duration was 86 days; probability of decolonization in 1 year was 98.5%, suggesting that CPE-carriers' status can be reviewed yearly. Prolonged carriage was associated with use of antimicrobial drugs.

引用

页码：2182 / 2185

页数：4

共 50 条

[21] Carbapenemase-producing Enterobacteriaceae, US rivers
Aubron, C
Poirel, L
Ash, RJ
Nordmann, P
EMERGING INFECTIOUS DISEASES, 2005, 11 (02) : 260 - 264
[22] Therapeutic options for carbapenemase-producing Enterobacteriaceae
Salgado, Patricia
Gilsanz, Fernando
Maseda, Emilio
REVISTA ESPANOLA DE QUIMIOTERAPIA, 2015, 28 : 12 - 15
[23] Carbapenemase-Producing Enterobacteriaceae in Spain in 2012
Oteo, Jesus
Saez, David
Bautista, Veronica
Fernandez-Romero, Sara
Manuel Hernandez-Molina, Juan
Perez-Vazquez, Maria
Aracil, Belen
Campos, Jose
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (12) : 6344 - 6347
[24] Global Spread of Carbapenemase-producing Enterobacteriaceae
Nordmann, Patrice
Naas, Thierry
Poirel, Laurent
EMERGING INFECTIOUS DISEASES, 2011, 17 (10) : 1791 - 1798
[25] Emergence of carbapenemase-producing Enterobacteriaceae in Malawi
Lewis, Joseph M.
Lester, Rebecca
Mphasa, Madalitso
Banda, Rachel
Edwards, Thomas
Thomson, Nicholas R.
Feasey, Nicholas
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 20 : 225 - 227
[26] Rapid Detection of Carbapenemase-producing Enterobacteriaceae
Nordmann, Patrice
Poirel, Laurent
Dortet, Laurent
EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1503 - 1507
[27] Strategies for identification of carbapenemase-producing Enterobacteriaceae
Nordmann, Patrice
Poirel, Laurent
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (03) : 487 - 489
[28] Lateral flow immunochromatographic assay for rapid screening of faecal carriage of carbapenemase-producing Enterobacteriaceae
Fauconnier, Charlotte
Dodemont, Magali
Depouhon, Angelique
Anantharajah, Ahalieyah
Verroken, Alexia
Rodriguez-Villalobos, Hector
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (02) : 357 - 359
[29] Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity
Castagnola, Elio
Tatarelli, Paola
Mesini, Alessio
Baldelli, Ivana
La Masa, Daniela
Biassoni, Roberto
Bandettini, Roberto
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2019, 12 (02) : 270 - 274
[30] Patient experience of hospital screening for carbapenemase-producing Enterobacteriaceae: A qualitative study
King, Caroline
Grandison, Tracyanne
Cawthorne, Julie
Currie, Kay
JOURNAL OF CLINICAL NURSING, 2019, 28 (21-22) : 3890 - 3900

← 1 2 3 4 5 →